Tirzepatide is one of the most advanced medications used in physician-supervised weight management. It works by targeting both GLP-1 and GIP hormone pathways to help regulate appetite, improve fullness, and support structured fat loss.
Whether your goal is 10 pounds or 70 pounds, the strategy depends on your starting BMI, medical history, dose titration, and consistency with follow-up.
Results vary. Timelines depend on individual factors. Medical supervision required.
Tirzepatide activates two metabolic pathways:
Together, these effects may:
Tirzepatide is the active ingredient in FDA-approved medications such as Mounjaro® and Zepbound™. Compounded tirzepatide is prepared by licensed compounding pharmacies pursuant to a prescription and is not an FDA-approved brand-name drug.
Ten pounds is often the first milestone.
For many patients, 10 pounds is achievable with consistent dosing and dietary awareness.
Fifteen pounds typically requires:
At this stage, fat loss becomes more noticeable in body composition.
Twenty pounds is a common weight-loss target.
Consistency becomes more important than speed.
Moderate weight loss requires:
Patients who remain compliant often see steady monthly progress.
Contact Dr. Terushkin and His Team Today!
Start Your Physician-Supervised Weight Loss Journey. (954) 551-3508
Higher weight-loss goals require:
Appetite control stabilizes.
Consistent fat reduction.
Focus shifts toward sustainability and maintenance planning.
Significant weight reduction requires:
There are no guaranteed timelines. Larger goals require patience and structure.
Progress depends on:
Two patients on the same medication may progress at different rates.
Adults who:
Eligibility is determined after medical evaluation.
Tirzepatide may cause:
Gradual dose titration improves tolerability.
Medical supervision reduces risk.
Tirzepatide is not a shortcut — it is a medical tool that supports appetite regulation. Long-term success depends on structured follow-up, nutrition, strength training, and realistic expectations.
Safe, steady progress is the goal.
This article is for educational purposes only. Tirzepatide requires medical evaluation and prescription. Compounded tirzepatide is not an FDA-approved brand-name drug. Results vary. Timelines depend on individual factors. Medical supervision required.
Dr. Sergey Terushkin, MD, FACS is a board-certified bariatric surgeon and medical weight loss specialist practicing in Florida. He provides physician-supervised obesity treatment, including GLP-1–based weight management and advanced bariatric surgery.
A Fellow of the American College of Surgeons (FACS), Dr. Terushkin combines evidence-based care with individualized treatment planning. All medical weight loss programs are prescribed after evaluation and include ongoing supervision.
Useful Links:
Real people, REAL RESULTS! Check out a few of the many people that we have helped reach their ideal weight goals over the years.
